SYSTEM AND METHODS FOR PULMONARY EDEMA DETECTION WITH IMPLANTABLE ACOUSTIC DEVICES

• US 20110009746A1
• Filed: 07/08/2010
• Published: 01/13/2011
• Est. Priority Date: 07/10/2009
• Status: Abandoned Application

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Zhang, Yunlong, Tran, Binh C., Mi, Bin
• Application Number:
  US12/832,554
• Publication Number:
  US 20110009746A1
• Time in Patent Office: Days
• US Class Current: 600/437
• CPC Class Codes: A61B 5/4878 Evaluating oedema
• CPC Class Codes: A61B 8/08 Detecting organic movements or changes, e.g. tumours, cysts, swellings A61B8/02 - A61B8/06 take precedence
• CPC Class Codes: A61B 8/12 in body cavities or body tracts, e.g. by using catheters catheters per se A61M25/00

Abstract

A system includes a first implantable acoustic transducer, a second implantable transducer a memory circuit, and a processor. The first implantable acoustic transducer is configured to receive transmitted acoustic energy from a thorax region of a subject and the second implantable acoustic transducer is configured to transmit the acoustic energy to the thorax region. The processor is communicatively coupled to the first acoustic transducer, the second acoustic transducer, and the memory circuit. The processor includes a parameter module configured to measure a parameter of the received acoustic energy, and a trending module configured to trend the measured parameter and to provide an indication of pulmonary edema status of the subject using the parameter trend.

Claims

1. A system comprising:

a first implantable acoustic transducer, wherein the first implantable acoustic transducer is configured to receive transmitted acoustic energy from a thorax region of a subject;

a second implantable acoustic transducer, wherein the second implantable acoustic transducer is configured to transmit the acoustic energy to the thorax region;

a memory circuit; and

a processor communicatively coupled to the first acoustic transducer, the second acoustic transducer, and the memory circuit, wherein the processor includes;

a parameter module configured to measure a parameter of the received acoustic energy; and

a trending module configured to trend the measured parameter and to provide an indication of pulmonary edema status of the subject using the parameter trend.

2. The system of claim 1, wherein a single implantable medical device (IMD) includes the first and second acoustic transducers.

3. The system of claim 2, wherein the parameter module is configured to measure at least one of:

a time interval from when the acoustic energy is transmitted to when the acoustic energy is received;

an amplitude of the received acoustic energy;

an attenuation of the received acoustic energy from the transmitted acoustic energy; and

a frequency dependence of the received acoustic energy, and

wherein the trending module is configured to trend a change in one or more of the time interval, the amplitude of the received acoustic energy, the attenuation of the received acoustic energy, and the frequency dependence of the received acoustic energy.

4. The system of claim 2, wherein the IMD includes an implantable lead, wherein the implantable lead includes the first implantable transducer.

5. The system of claim 2, wherein the IMD includes an implantable lead, wherein the implantable lead includes the second implantable transducer.

6. The system of claim 1, including:

a first device having the first implantable acoustic transducer, the memory circuit, and the processor; and

a second device having the second implantable acoustic transducer, and

wherein the parameter module of the processor in the first device is configured to measure at least one of;

an amplitude of the received acoustic energy; and

a frequency dependence of the received acoustic energy, and

wherein the trending module is configured to trend a change in one or more of the amplitude of the received acoustic energy, and the frequency dependence of the received acoustic energy.

7. The system of claim 1, wherein the parameter module is configured to measure received transmissions of pulsed acoustic energy.

8. The system of claim 1, wherein the parameter module is configured to measure a received transmission of acoustic energy that is continuous over a plurality of respiration cycles.

9. The system of claim 1, including an implantable respiration sensor communicatively coupled to the processor and configured to provide a sensor signal representative of respiration, and

wherein the parameter module is configured to measure the parameter of acoustic energy in relation to a specified phase of a respiration cycle of the subject.

10. A system comprising:

an implantable acoustic transducer configured to transmit acoustic energy to a thorax region of a subject and to receive acoustic energy reflected from the thorax region;

a memory circuit; and

a processor communicatively coupled to the implantable acoustic transducer and the memory circuit, wherein the processor includes;

a parameter module configured to measure a parameter of the received reflected acoustic energy; and

a trending module configured to trend the measured parameter and to provide an indication of pulmonary edema status of the subject using the parameter trend, and

wherein the parameter module is configured to measure at least one of;

a time interval from when the acoustic energy is transmitted to when the reflected acoustic energy is received;

an amplitude of the received reflected acoustic energy; and

an attenuation of the received reflected acoustic energy from the transmitted energy, and

wherein the trending module is configured to trend a change in one or more of the time interval, the amplitude of the received reflected acoustic energy, or the attenuation of the received reflected acoustic energy.

11. The system of claim 10, including an implantable respiration sensor communicatively coupled to the processor and configured to provide a sensor signal representative of respiration, and

wherein the parameter module is configured to measure the parameter of acoustic energy in relation to a specified phase of a respiration cycle of the subject.

12. A method comprising:

receiving acoustic energy from a thorax region of a subject using a first implantable acoustic transducer;

transmitting the acoustic energy to the thorax region using a second implantable acoustic transducer;

trending a parameter of the received acoustic energy using a medical device; and

indicating, to a user or process, a pulmonary edema status of the subject using the trended parameter.

13. The method of claim 12, including measuring at least one of:

an amplitude of the received acoustic energy;

an attenuation of the received acoustic energy from the transmitted acoustic energy; and

a time interval from when the acoustic energy is transmit to when the acoustic energy is received, and

wherein trending the parameter includes trending a change in one or more of the amplitude of the received acoustic energy, the attenuation of the received acoustic energy, or the time interval.

14. The method of claim 12, including:

sweeping a frequency of the transmitted acoustic energy over a specified frequency range using the IMD; and

measuring a frequency dependence of the received acoustic energy, and

wherein trending the parameter includes trending the frequency dependence of the received acoustic energy.

15. The method of claim 12, wherein transmitting the acoustic energy includes transmitting acoustic energy having a frequency in a range of 20 kHz to 500 kHz.

16. The method of claim 12, wherein transmitting the acoustic energy includes transmitting acoustic energy having a frequency in a range of 1 kHz to 20 kHz.

17. The method of claim 12,

wherein receiving acoustic energy includes receiving information telemetered using acoustic energy at a first device,

wherein transmitting acoustic energy includes transmitting the telemetered information to the first device using a second device,

wherein the method includes measuring an amplitude of the received acoustic energy, and

wherein trending the parameter includes trending a change in the amplitude measurement.

18. The method of claim 12, including:

receiving a sensor signal representative of at least one of pulmonary arterial pressure (PAP) and transthoracic impedance, and

wherein indicating a pulmonary edema status includes determining the pulmonary edema status using the trended parameter and the sensor signal.

19. The method of claim 12, including:

determining a respiration cycle of the subject using a received sensor signal that is representative of respiration, and

wherein trending the parameter includes measuring the parameter in relation to a specified phase of a respiration cycle of the subject.

20. A method comprising:

transmitting acoustic energy to a thorax region of a subject using an implantable acoustic transducer;

receiving a reflection of the transmitted acoustic energy at the implantable acoustic transducer;

measuring, using a medical device, at least one of;

an amplitude of the received reflected acoustic energy;

an attenuation of the received reflected acoustic energy from the transmitted acoustic energy; and

a time interval from when the acoustic energy is transmit to when the reflected acoustic energy is received;

trending a change in one or more of the amplitude of the received reflected acoustic energy, the attenuation of the received reflected acoustic energy, and the time interval; and

indicating, to a user or process, a pulmonary edema status of the subject using the trend.